Last reviewed · How we verify
DAPT — Competitive Intelligence Brief
marketed
Outer membrane porin protein OmpD
Infectious Disease
Small molecule
Live · refreshed every 30 min
Target snapshot
DAPT (DAPT) — Baxter Hlthcare Corp. Dapt is a small molecule that works by interacting with specific biological targets, but the exact details of this interaction are unknown.
Comparator set (1 drugs)
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| DAPT TARGET | DAPT | Baxter Hlthcare Corp | marketed | Outer membrane porin protein OmpD | ||
| Cubicin | Cubicin | Clinical Alliance for Research & Education - Infectious Diseases, LLC. | marketed | Outer membrane porin protein OmpD |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
Cite this brief
Drug Landscape (2026). DAPT — Competitive Intelligence Brief. https://druglandscape.com/ci/dapt. Accessed 2026-05-13.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab